Enhancing the efficiency of direct reprogramming of humanmesenchymal stem cells into mature neuronal-like cells with thecombination of small molecule modulators of chromatin modifyingenzymes, SMAD signaling and cyclic adenosine monophosphate levels

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 8, 2013, Pages 1633-1638

  Alexanian, Arshak R ^a   Liu, Qing Song ^a,b   Zhang, Zhiying ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Epigenetics; Mesenchymal; Neuronal; Reprogramming; Stem cells

Indexed keywords

4 AMINOBUTYRIC ACID; CYCLIC AMP; ENZYME; MICROTUBULE ASSOCIATED PROTEIN 2; NERVE CELL ADHESION MOLECULE; SMAD PROTEIN; VESICULAR GLUTAMATE TRANSPORTER 1;

ARTICLE; CELL COUNT; CELL MATURATION; CELL MEMBRANE; CELL REPROGRAMMING; CELL TRANSDIFFERENTIATION; CHEMICAL GENETICS; CHROMATIN; CHROMATIN STRUCTURE; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCHYMAL STEM CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PHENOTYPE; PLASTICITY; POTASSIUM CURRENT; PROCEDURES CONCERNING CELLS; SODIUM CURRENT; SYNAPSE; WESTERN BLOTTING;

EID: 84884848438     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.04.022     Document Type: Article

References (21)

1. Alexanian AR. An efficient method for generation of neural-like cells from adulthuman bone marrow-derived mesenchymal stem cells. Regenerative Medicine 2010;5:891-900..
2. Anastasia L, Piccoli M, Garatti A, Conforti E, Scaringi R, Bergante S, et al. Cell reprogramming: a new chemical approach to stem cell biologyand tissue regeneration. Current Pharmaceutical Biotechnology 2011;12:146-50..
3. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highlyefficient neural conversion of human ES and iPS cells by dual inhibition of SMADsignaling. Nature Biotechnology 2009;27:275-80..
4. Chen Y, Pan RL, Zhang XL, Shao JZ, Xiang LX, Dong XJ, et al. Induction of hepaticdifferentiation of mouse bone marrow stromal stem cells by the histonedeacetylase inhibitor VPA. Journal of Cellular and Molecular Medicine 2009;13:2582-92..
5. Emre N, Coleman R, Ding S. A chemical approach to stem cell biology. Current Opinion in Chemical Biology 2007;11:252-8.. (Pubitemid 46963068)
6. Harris DM, Hazan-Haley I, Coombes K, Bueso-Ramos C, Liu J, Liu Z, et al. Transforma-tion of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS ONE 2011;6:e21250..
7. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, et al. Induction ofpluripotent stem cells by defined factors is greatly improved by small-moleculecompounds. Nature Biotechnology 2008;26:795-7.. (Pubitemid 351961456)
8. Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, Kim HS, et al. Robust enhancement of neuraldifferentiation from human ES and iPS cells regardless of their innate differencein differentiation propensity. Stem Cell Reviews 2010;6:270-81..
9. Kishigami S, Mizutani E, Ohta H, Hikichi T, Thuan NV, Wakayama S, et al. Signifi-cant improvement of mouse cloning technique by treatment with trichostatin Aafter somatic nuclear transfer. Biochemical and Biophysical Research Commu-nications 2006;340:183-9.. (Pubitemid 41827663)
10. Li W, Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends in Pharmacological Sciences 2010;31:36-45..
11. Lyssiotis CA, Walker J, Wu C, Kondo T, Schultz PG, Wu X. Inhibition of histonedeacetylase activity induces developmental plasticity in oligodendrocyte pre-cursor cells. Proceedings of the National Academy of Sciences of the United States of America 2007;104:14982-7.. (Pubitemid 47619579)
12. Rybouchkin A, Kato Y, Tsunoda Y. Role of histone acetylation in reprogramm-ing of somatic nuclei following nuclear transfer. Biology of Reproduction 2006;74:1083-9.. (Pubitemid 47394287)
13. Sachinidis A, Sotiriadou I, Seelig B, Berkessel A, Hescheler J. A chemical genet-ics approach for specific differentiation of stem cells to somatic cells: a newpromising therapeutical approach. Combinatorial Chemistry & High Throughput Screening 2008;11:70-82..
14. Schmittwolf C, Kirchhof N, Jauch A, Durr M, Harder F, Zenke M, et al. In vivohaematopoietic activity is induced in neurosphere cells by chromatin-modifyingagents. EMBO Journal 2005;24:554-66.. (Pubitemid 40343257)
15. Schugar RC, Robbins PD, Deasy BM. Small molecules in stem cell self-renewal and differentiation. Gene Therapy 2008;15:126-35..
16. Sumer H, Liu J, Verma PJ. Cellular reprogramming of somatic cells. Indian Journal ofExperimental Biology 2011;49:409-15..
17. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, et al.A new method for the rapid and long term growth of human neural precursorcells. Journal of Neuroscience Methods 1998;85:141-52.. (Pubitemid 29003064)
18. Xu Y, Shi Y, Ding S. A chemical approach to stem-cell biology and regenerativemedicine. Nature 2008;453:338-44.. (Pubitemid 351693140)
19. Zhang Z, Alexanian AR. Dopaminergic-like cells from epigenetically repro-grammed mesenchymal stem cells. Journal of Cellular and Molecular Medicine 2012a;16:2708-14..
20. Zhang Z, Alexanian AR. The neural plasticity of early-passage human bonemarrow-derived mesenchymal stem cells and their modulation with chromatin-modifying agents. Journal of Tissue Engineering and Regenerative Medicine 2012b, in press..
21. Zhang Z, Maiman DJ, Kurpad SN, Crowe MJ, Alexanian AR. Feline bone marrow-derived mesenchymal stem cells express several pluripotent and neural markersand easily turn into neural-like cells by manipulation with chromatin mod-ifying agents and neural inducing factors. Cellular Reprogramming 2011;13:385-90..